PIK3CA and neoplasm: This study investigates the genomic alterations that are associated with response to PI3K inhibition and identifies mechanisms of resistance to PI3K inhibition using baseline and end‐of‐treatment circulating tumour DNA (ctDNA) from patients enrolled in SANDPIPER (NCT02340221).